BNRI, Vaccine Solutions deal

Bavarian Nordic Research Institute (CSE:BNRI) received exclusive global rights to Vaccine Solutions' Polytope technology for use in BNRI's epitope-based vaccine for HIV. BNRI will incorporate the tech...